Navigation Links
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director
Date:1/16/2010

>the introduction and impact of competitive products and pricing, including as a result of so-called authorized-generic drugs;
  • new product development and launch, including the possibility that any product launch may be delayed;
  • reliance on key strategic alliances;
  • the availability of raw materials and/or products manufactured for the Company under contract manufacturing arrangements with third parties;
  • the regulatory environment, including regulatory agency and judicial actions and changes in applicable law or regulations;
  • fluctuations in revenues;
  • the difficulty of predicting international regulatory approvals, including timing;
  • the difficulty of predicting the pattern of inventory movements by the Company's customers;
  • the impact of competitive response to the Company's sales, marketing and strategic efforts, including the introduction or potential introduction of generic or competing products against products sold by the Company and its subsidiaries;
  • risks that the Company may not ultimately prevail in litigation, including challenges to the Company's intellectual property rights by actual or potential competitors or to the Company's ability to market generic products due to brand company patents and challenges to other companies' introduction or potential introduction of generic or competing products by third parties against products sold by the Company or its subsidiaries, including without limitation the litigation and claims referred to in Note 16 of the Notes to the Consolidated Financial Statements in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2008 and under the heading "Certain Other Matters" in the Company's Form 8-K filed with the SEC on April 30, 2009;
  • the possibility that the Company's current estimates of the financial effect of certain announced product recalls could prove to be incorrect;
  • whether any product recalls or
    '/>"/>

  • SOURCE KV Pharmaceutical Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
    (Date:10/22/2014)... Oct. 21, 2014   BioNano Genomics , ... genomics research centers to purchase an Irys™ System ... National Cancer Institute (NCI), NIH Intramural Sequencing Center (NISC) ... Irys, obtaining a comprehensive view of a genome ... (NGS) does not deliver the scalability or reliability ...
    (Date:10/22/2014)... WESTMINSTER, Colo. , Oct. 22, 2014   ... class of infusion systems designed to maximize targeted delivery ... is pleased to announce that oncologist John R. ... Norris Comprehensive Cancer Center, and surgical oncologist Steven ... Center have joined the Company,s Scientific Advisory Board (SAB).  ...
    Breaking Medicine Technology:Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2
    ... , ... Reportlinker.com announces that a new market research report ... Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to ... Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to ...
    ... , , COVINA, Calif., Nov. ... agreement with Academia Sinica, the National Laboratory of Taiwan, for ... treatment of Chronic Stroke with stem cells. This method ... John Lin, MD, PhD and members of Academia Sinica. ...
    Cached Medicine Technology:Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3
    (Date:10/25/2014)... Dallas, TX (PRWEB) October 25, 2014 ... and Chinese Molecular Diagnostics Industry, 2009-2019 is ... Global and Chinese Molecular Diagnostics industry. The ... Molecular Diagnostics including its classification, application and ... and China’s top manufacturers of Molecular Diagnostics ...
    (Date:10/25/2014)... (PRWEB) October 25, 2014 Limbkeepers® announced ... episode of Innovations with Ed Begley Jr, airing 1st ... TBA. , In this episode, Innovations will focus on ... to protect fragile, thinning skin on arms, hands, and ... learn about these versatile products, which help reduce injuries, ...
    (Date:10/25/2014)... 23, 2014 (HealthDay News) -- A large influx of ... is to avoid tens of thousands of deaths from ... researchers predict. Using a specially designed mathematical ... the outbreak in just one densely populated county of ... city of Monrovia. The researchers said that if ...
    (Date:10/22/2014)... On Saturday, October 25, 2014, the Brownsville Community Health ... fitness fair ¡Vive tu vida! Get Up! Get Moving!®. The ... better health and wellness for people of all ages and ... the public, will be held at Dean Porter Park, 501 ... pm. , “¡Vive tu Vida! Get Up! Get Moving!® ...
    (Date:10/22/2014)... Amy Norton HealthDay Reporter ... remain riveted on the three Ebola cases in Dallas. But, ... health threat to Americans. President Barack Obama on Friday ... the virus, which has infected two Dallas nurses who cared ... at Texas Health Presbyterian Hospital. But the U.S. cases ...
    Breaking Medicine News(10 mins):Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3
    ... Assam still deprived of modern health infrastructure , a private ... islands of the river Brahmaputra. ,The Centre for ... in 2000, has started the Ships of Hope in a ... are conducting camps in the islands of the Brahmaputra. ...
    ... miscarriage and irregular numbers of chromosomes (aneuploidy) in neonates. ... Institutet published in the scientific journal Nature Genetics shows ... formed. ,Sex cells contain a control station ... numbers of chromosomes are distributed during cell division. ...
    ... the Internet for conditions ranging from cold sores and ... sold to prevent aging, enhance fertility, prevent cancer and ... and cadmium. , ,Selenium supplements have shown ... antioxidant activities, some scientists feel it might be effective ...
    ... of antibiotic could prevent cancer patients from losing hair during ... ,Toshiyuki Sakai said his team had found "alopestatin" ... also given etoposide anti-cancer drugs. ,Etoposide is widely ... hair loss. ,Sakai, professor at Kyoto Prefectural University ...
    ... at Children's National Medical Center have identified a fundamental ... of the brain . ,The signalling ... is significant for myelination and remyelination, the processes essential ... matter. ,The groundbreaking discovery in mouse ...
    ... alarmed physicians and public health officials, and ,veterinarians ... and cats . ,Now, a team ... Veterinary Medicine ,(VMRCVM) and the College of Agriculture ... ,determined that horses are also facing serious health ...
    Cached Medicine News:Health News:Ships to the Rescue of Medically Deprived Assamese 2Health News:Selenium Supplements Could Increase Diabetes Risk 2Health News:Selenium Supplements Could Increase Diabetes Risk 3Health News:Protein Instrumental to Brain Development and Repair Identified 2Health News:Fat Horses Face Health Problems 2Health News:Fat Horses Face Health Problems 3Health News:Fat Horses Face Health Problems 4Health News:Fat Horses Face Health Problems 5
    ... lightweight self-adhesive insulin pod that you fill with ... up to three days and then replace. The ... your body through a small flexible tube (called ... into its wireless companion, the Personal Diabetes Manager. ...
    The MiniMed Paradigm REAL-Time System is the world's first system to integrate an insulin pump with REAL-Time continuous glucose monitoring, taking diabetes management to a level you just can't achie...
    The IR 1000 Insulin Infusion Pump from Animas offers unprecedented safety features, performance, and convenience....
    ... premium product for acne, XtremeClear, powered ... on a scalable multi-application platform. A ... acne, XtremeClear works fast, providing noticeable ... treatments. Uncompromising safety in each of ...
    Medicine Products: